Cover Image
Market Research Report

Hand Dermatitis Global Clinical Trials Review, H2, 2017

Published by GlobalData Product code 340874
Published Content info 60 Pages
Immediate Delivery Available
Price
Back to Top
Hand Dermatitis Global Clinical Trials Review, H2, 2017
Published: August 31, 2017 Content info: 60 Pages
Description

GlobalData's clinical trial report, "Hand Dermatitis Global Clinical Trials Review, H2, 2017" provides an overview of Hand Dermatitis clinical trials scenario. This report provides top line data relating to the clinical trials on Hand Dermatitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents
Product Code: GDHC4538CTIDB

Table of Contents

Table of Contents

Table of Contents 2

  • List of Tables 3
  • List of Figures 3
  • Report Guidance 4
  • GlobalData Clinical Trials Report Coverage 5
  • Clinical Trials by Region 6
  • Clinical Trials and Average Enrollment by Country 7
  • Top Countries Contributing to Clinical Trials in Asia-Pacific 10
  • Top Five Countries Contributing to Clinical Trials in Europe 11
  • Top Countries Contributing to Clinical Trials in North America 12
  • Top Countries Contributing to Clinical Trials in Middle East and Africa 13
  • Clinical Trials by G7 Countries: Proportion of Hand Dermatitis to Dermatology Clinical Trials 14
  • Clinical Trials by Phase in G7 Countries 15
  • Clinical Trials in G7 Countries by Trial Status 16
  • Clinical Trials by E7 Countries: Proportion of Hand Dermatitis to Dermatology Clinical Trials 17
  • Clinical Trials by Phase 18
  • In Progress Trials by Phase 19
  • Clinical Trials by Trial Status 20
  • Clinical Trials by End Point Status 21
  • Subjects Recruited Over a Period of Time 22
  • Clinical Trials by Sponsor Type 23
  • Prominent Sponsors 24
  • Top Companies Participating in Hand Dermatitis Therapeutics Clinical Trials 26
  • Prominent Drugs 27
  • Clinical Trial Profile Snapshots 28

Appendix 58

  • Abbreviations 58
  • Definitions 58
  • Research Methodology 59
  • Secondary Research 59
  • About GlobalData 60
  • Contact Us 60
  • Source 60

List of Tables

List of Tables

  • Hand Dermatitis Therapeutics, Global, Clinical Trials by Region, 2017* 6
  • Hand Dermatitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
  • Hand Dermatitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
  • Hand Dermatitis Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2017* 10
  • Hand Dermatitis Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 11
  • Hand Dermatitis Therapeutics Clinical Trials, North America, Top Countries, 2017* 12
  • Hand Dermatitis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2017* 13
  • Proportion of Hand Dermatitis to Dermatology Clinical Trials, G7 Countries (%), 2017* 14
  • Hand Dermatitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 15
  • Hand Dermatitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 16
  • Proportion of Hand Dermatitis to Dermatology Clinical Trials, E7 Countries (%), 2017* 17
  • Hand Dermatitis Therapeutics, Global, Clinical Trials by Phase, 2017* 18
  • Hand Dermatitis Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 19
  • Hand Dermatitis Therapeutics, Global, Clinical Trials by Trial Status, 2017* 20
  • Hand Dermatitis Therapeutics Clinical Trials, Global, by End Point Status, 2017* 21
  • Hand Dermatitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 22
  • Hand Dermatitis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 23
  • Hand Dermatitis Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 25
  • Hand Dermatitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 26
  • Hand Dermatitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 27

List of Figures

List of Figures

  • Hand Dermatitis Therapeutics, Global, Clinical Trials by Region (%), 2017* 6
  • Hand Dermatitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7
  • Hand Dermatitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
  • Hand Dermatitis Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2017* 10
  • Hand Dermatitis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 11
  • Hand Dermatitis Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 12
  • Proportion of Hand Dermatitis to Dermatology Clinical Trials, G7 Countries (%), 2017* 14
  • Hand Dermatitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 15
  • Hand Dermatitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 16
  • Proportion of Hand Dermatitis to Dermatology Clinical Trials, E7 Countries (%), 2017* 17
  • Hand Dermatitis Therapeutics, Global, Clinical Trials by Phase (%), 2017* 18
  • Hand Dermatitis Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 19
  • Hand Dermatitis Therapeutics, Global, Clinical Trials by Trial Status, 2017* 20
  • Hand Dermatitis Therapeutics Clinical Trials, Global, by End Point Status, 2017* 21
  • Hand Dermatitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 22
  • Hand Dermatitis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 23
  • Hand Dermatitis Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 24
  • Hand Dermatitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 26
  • Hand Dermatitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 27
  • GlobalData Methodology 59
Back to Top